Interstitial cystitis/ bladder pain syndrome (IC/BPS) is a chronic inflammation that results in recurring pain in the bladder and the surrounding pelvic region caused by abnormal excitability of micturition reflexes. Spinal cord stimulation (SCS) is currently in clinical use for the attenuation of neuropathic pain, and has been identified for amelioration of pain in a rodent model of colorectal distention. This study aimed to investigate the potential effect of SCS on attenuation of visceral pain-related visceromotor reflexes (VMR) in rodents with cyclophosphamide-induced cystitis.
INTRODUCTION AND OBJECTIVES:
Interstitial cystitis/ bladder pain syndrome (IC/BPS) is a chronic inflammation that results in recurring pain in the bladder and the surrounding pelvic region caused by abnormal excitability of micturition reflexes. Spinal cord stimulation (SCS) is currently in clinical use for the attenuation of neuropathic pain, and has been identified for amelioration of pain in a rodent model of colorectal distention. This study aimed to investigate the potential effect of SCS on attenuation of visceral pain-related visceromotor reflexes (VMR) in rodents with cyclophosphamide-induced cystitis.
METHODS: Female Sprague-Dawley rats underwent intraperitoneal injection of cyclophosphamide (CYP, n¼8) or saline (controls, n¼4). 48 hours after CYP or saline injections, all rats underwent surgical preparations under urethane anesthesia. Stimulation wires were placed on the dorsal surface of the spinal segments of L2 and L3 for SCS. A PE-50 tubing was inserted into the bladder to obtain the intravesical pressure (IVP). Two wires are placed in the left external abdominal oblique muscle to record VMR. Before and after SCS (40 Hz, 0.2 ms for 25 min), VMR and maximum intravesical pressure (IVPmax) were obtained during continuous bladder infusion and isotonic bladder distention (IBD).
RESULTS: During continuous bladder infusion (Fig 1A) , the ratio of VMR threshold/IVPmax was significantly decreased in CYP rats indicating early VMR appearance compared to controls. SCS significantly increased the ratio indicating the delayed VMR appearance.
During IBD with urethral occlusion, SCS delayed the latency of VMR appearance in CYP rats below the voiding thresholds at 10 and 20 cmH2O. SCS also significantly decreased VMR area under the curve (AUC) in CYP rats (Figs 1B-C) .
CONCLUSIONS: SCS attenuated visceral pain-related VMR in rats with CYP-induced cystitis suggesting a role for SCS in modulating visceral nociception and hyperalgesia. SCS appears to be a potential treatment of IC/PBS. INTRODUCTION AND OBJECTIVES: While bladder hypersensitivity syndromes (BHS), such as overactive bladder (OAB) and interstitial cystitis/painful bladder syndrome (IC/PBS), classically exhibit the predominant symptoms of urgency and bladder pain, respectively, there is considerable symptom overlap between the conditions. Given this finding, we sought to define the fundamental features of each syndrome and refine diagnostic criteria through retrospective comparison of self-reported symptoms in female patients with a range of clinical presentations and symptom severities.
METHODS: We performed univariate analysis comparing responses to the Genitourinary Pain Index (GUPI), OAB Questionnaire (OABq) and O'Leary-Sant Indices (ICSI/ICPI) between 26 asymptomatic, 42 IC/PBS, and 27 OAB patients. Only five specific questions differed significantly between the IC/PBS and OAB groups, which assessed either urgency incontinence or bladder pain with filling. We used these questions to generate a novel composite scoring system with urgency incontinence (UI) and bladder pain (BP) domains to differentiate these populations.
RESULTS: While all validated questionnaires could distinguish between controls and BHS, no composite symptom scores differed significantly between the IC/PBS and OAB patients ( Figure 1A ). Only the GUPI Pain Domain was significantly different between OAB and IC/ PBS patients, but was not useful for diagnostic evaluation, resulting in a Positive Predictive Value (PPV) of only 56-60% for a range of cutoffs. Our composite score gave a PPV of 100% and Negative Predictive e406 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 
